EMA Broadens Valsartan Contamination Investigation By Sam | September 21, 2018 The EMA expanded its investigation of valsartan impurities after a new contaminant was discovered in an Indian manufacturer’s active substance, losartan. Source: Drug Industry Daily Posted in Drug Industry Daily